James Gilbert, for over 35 years, has been an advisor, executive, and investor in the healthcare industry. In addition to representing Flagship Ventures on the TransMedics board, he is on the board of Rubius Therapeutics, a Flagship VentureLabs company. Mr. Gilbert is also a board member of ECG Hospital Consultants, Nestlé Health Science S.A., National Dentex Corporation, and serves as an advisor to General Atlantic. From 2004 to 2010 Mr. Gilbert was Executive Vice President of Boston Scientific. Prior to joining Boston Scientific, Mr. Gilbert spent 23 years as a partner and director at Bain & Company with responsibility for their Global Healthcare Practice. Mr. Gilbert has also served as a lecturer at Babson College. Mr. Gilbert has a BS from Cornell University and an MBA from Harvard Business School.